Imaging Core Facilities
The BioMedical Engineering and Imaging Institute (BMEII) is responsible for providing support for all in-vivo imaging research at Mount Sinai. The Imaging Core Facility (the Core) is the backbone of BMEII and is responsible for coordinating, supporting, and executing imaging research at Mount Sinai.
The Core supports all the image acquisition, image analysis, scheduling, and performance of the proposed experiments. The Core has an extensive and expanding inventory of preclinical (large and small) and clinical research imaging facilities and equipment.
The Core’s resources are fully supported by user fees drawn from research grants, instrumentation grants, industry contracts, and agreements. Our core facilities are available for use to all qualified investigators from academic, medical, government, and industry laboratories.
See our list of innovative technologies in biomedical imaging that address basic and clinical research problems which improve human health.
Please go to Calpeno to schedule a scan time and XNAT to access our imaging archive
MRI Safety Training
Simple but thorough set of guidelines that anyone involved with using the BMEII facilities must follow
Get information on pricing and fees, including study consultation, facilities and equipment
Subtle changes in an individual’s heartbeat, which can be measured on an Apple Watch, are able to signal the onset of COVID-19 up to seven days before individuals are diagnosed with the infection. That preliminary observation was made by researchers at the Icahn...
Mount Sinai Hospital opens one of the first centers to study and treat people with what being called “Post-acute COVID Syndrome.”
Please click on the image to watch the 60 Minutes segment. New York, NY (November 22, 2020) — COVID-19 was initially thought to be a disease that was serious for the eldery and people with preexisting conditions. A potentially tough, but temporary respiratory illness...
Nanobiologic immunotherapy uses tiny, bioengineered material to harness immune systemNew York, NY (October 29, 2020) — A groundbreaking new type of cancer immunotherapy developed at the Icahn School of Medicine at Mount Sinai trains the innate immune system to help it...
Artificial intelligence–enabled rapid diagnosis of patients with COVID-19
Xueyan Mei, Hao-Chih Lee, […] Yang Yang
Nat Med (2020).
Probing myeloid cell dynamics in ischaemic heart disease by nanotracer hot-spot imaging
Max L. Senders, Anu E. Meerwaldt, ... Willem J. M. Mulder
Nat. Nanotechnol. 15, 398–405 (2020).